Dr. Andrew J. Decrescenzo, MD

  • Spring, TX
  • Dermatologist
NPI1003342833PAC ID7214283662
Medicare services, 2024
6,668
Medicare patients, 2024
2,469
Part D claims, 2024
923
Publications
14
Clinical trials
10
Practice address
9303 Pinecroft Dr, Spring, TX 77380
Practice phone
Call (281) 363-5050
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

The Woodlands Dermatology Associates PA

Spring, Texas

See all 5 affiliations

Find Dr. Decrescenzo's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Andrew J. Decrescenzo is a dermatologist in Spring, Texas

Dr. Decrescenzo practices at The Woodlands Dermatology Associates PA in Spring, Texas.

Dr. Decrescenzo's NPI, 1003342833, was assigned on May 11, 2017. Dr. Decrescenzo graduated from UTMB Health in 2017. Dr. Decrescenzo holds Texas license S9489.

NPI and contact details
Medicare PAC ID
7214283662
NPI enumeration date
May 11, 2017
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(281) 363-5050
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
35
Medical school graduation
2017

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Andrew J. Decrescenzo practices at The Woodlands Dermatology Associates PA in Spring, Texas

Dr. Decrescenzo's primary practice is The Woodlands Dermatology Associates PA, at 9303 Pinecroft Dr, Spring, TX 77380 in Montgomery County. The practice phone is (281) 363-5050.

  • The Woodlands Dermatology Associates PA
    9303 Pinecroft Dr, Spring, TX 77380 · Montgomery CountyPhone(281) 363-5050

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Andrew J. Decrescenzo is affiliated with 2 sites of care and 3 medical groups

Dr. Decrescenzo's primary practice is The Woodlands Dermatology Associates PA in Spring, Texas. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Dr. Decrescenzo to 2 more medical groups and 1 group practice or clinic, each named with a free account.

See all 5 affiliations for Dr. Decrescenzo

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Andrew J. Decrescenzo's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Decrescenzo practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
The Woodlands Dermatology Associates PAAvailable with a free account
+1 more site and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Decrescenzo practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Andrew J. Decrescenzo is one of 1,073 dermatologists in Texas

Dermatology is Dr. Decrescenzo's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Decrescenzo is board certified in dermatology by the American Board of Dermatology. Dr. Decrescenzo is licensed in Texas.

Specialties and state licenses

  • Dermatology, TexasPrimaryLicense S9489 · 2021 to 2027 · taxonomy 207N00000X

Clinical focus

Dmand AI lists acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes, joint cyst and minor head injury among the conditions Dr. Decrescenzo treats.

Dermatologists near Dr. Decrescenzo

Counts of dermatologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Andrew J. Decrescenzo billed Medicare for 6,668 services in 2024

CMS data shows 6,668 Medicare services from Dr. Decrescenzo across 26 procedure codes in 2024, for 2,469 Medicare patients. Medicare paid $326,502 for them. Every service was in an office.

Medicare services, 20246,668
Medicare patients2,469
Paid by Medicare$326,502
Procedure codes26

Dr. Decrescenzo's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Lab and pathology
2023: 2,7152024: 4,08350%
Surgery
2023: 1,0162024: 1,74071%
Office and hospital visits
2023: 4932024: 83469%
Other services
2023: 02024: 11

Dr. Decrescenzo compared with the Texas median for dermatologists, 2024

  • Dr. Decrescenzo
  • Texas median
Medicare services
6,668vs 1,9823.4 times
Medicare patients
2,469vs 4655.3 times
Part D claims
805vs 43685% above

Medians across 1,030 dermatologists in Texas with Dmand AI profiles that report each measure.

Dr. Decrescenzo's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Decrescenzo

Need commercial claims for Dr. Decrescenzo?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Decrescenzo and other dermatologists in Texas.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Andrew J. Decrescenzo treated 2,469 Medicare patients in 2024, average age 75

CMS counts 2,469 Medicare patients who saw Dr. Decrescenzo in 2024. The largest group is 65 to 74, with 1,199 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Decrescenzo's median patient age at 60, with 50% women.

Medicare patients, 20242,469
Average age75
Average risk score1.02

Dr. Decrescenzo's Medicare patients by age, 2024

Dr. Decrescenzo's Medicare patients by sex, 2024

  • Women1,15247%
  • Men1,31753%

Chronic conditions among Dr. Decrescenzo's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure71%
  3. Arthritis48%
  4. Ischemic heart disease30%
  5. Diabetes20%
  6. Anxiety19%
  7. Atrial fibrillation19%
  8. Cancer19%

Share of Medicare patients with each condition. A patient can have several.

Dr. Decrescenzo's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 60

Patient panel by sex, all payers

  • Women50%
  • Men48%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Andrew J. Decrescenzo wrote 923 Medicare Part D claims in 2024

In 2024, Dr. Decrescenzo wrote 923 Medicare Part D claims for 366 patients. 92% of them were for generic drugs. CMS names the drug for 805 of them, across 18 drugs with 11 or more claims each, at $513,095 in total drug cost. In 2023, CMS named 286 claims across 10 drugs.

Part D claims, 2024923
Drugs named by CMS18
Total drug cost$513,095
Part D patients366

Dr. Decrescenzo's Part D claims by kind of drug, 2024

  • Generic853 claims92%
  • Brand-name70 claims8%

Dr. Decrescenzo's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Decrescenzo's Part D claims, 2024

  • Antibiotics6%54 of 923 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2862024: 805181%

Drugs named by CMS: 18 in 2024, 10 in 2023.

See all prescribing by Dr. Decrescenzo

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Andrew J. Decrescenzo scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Decrescenzo for performance year 2024, reported as part of a group. Dr. Decrescenzo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 460 procedures of skin biopsy by Dr. Decrescenzo, more than 95% of the clinicians it reports for that procedure.

Accepts Medicare assignment
Yes

Dr. Decrescenzo's MIPS scores, performance year 2024

  • 100of 100Final score
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Where Dr. Decrescenzo ranks in Medicare procedure volume

Removal of skin lesions
89th percentile665 procedures
Skin biopsy
95th percentile460 procedures
Removal or shaving of skin growth
87th percentile141 procedures
Melanoma (skin cancer) excision
85th percentile43 procedures

CMS ranks each clinician against every clinician it reports for the same procedure category.

Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find dermatologists like Dr. Decrescenzo by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Andrew J. Decrescenzo has 14 publications on record

Dmand AI links 14 papers to Dr. Decrescenzo, published from 2013 to 2021. 2016 was the busiest year, with 5. The most frequent topics are Vasculitis, Leukocytoclastic, Cutaneous. Dr. Decrescenzo has published most often in JAAD Case Rep. Dr. Decrescenzo's most frequent co-authors are Michael George Wilkerson, MD, Rebecca Catherine Philips, MD and Marcus Zaayman.

Papers14
Years published2013 to 2021

Dr. Decrescenzo's papers by year, 2013 to 2021

Topics Dr. Decrescenzo writes about most

  • Vasculitis, Leukocytoclastic, Cutaneous

Dr. Decrescenzo's most frequent co-authors

Recent publications by Dr. Decrescenzo

See all 14 publications and co-authors

See who Dr. Decrescenzo researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Decrescenzo works with, so you can find a warm path to the right dermatologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Andrew J. Decrescenzo has worked on 10 clinical trials

Dmand AI links Dr. Decrescenzo to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

Clinical trials with Dr. Decrescenzo by phase

  1. NonePhase 1: no trials
  2. 4Phase 2: 4 trials
  3. 1Phase 2/3: 1 trial
  4. NonePhase 3: no trials
  5. NonePhase 4: no trials

Trials with no phase (devices, behavioral studies) are left out.

Conditions in Dr. Decrescenzo's trials

  • Adenocarcinoma of Lung
  • Biliary Atresia
  • Low Back Pain
  • Malocclusion
  • Muscular Atrophy

Investigators on the most trials with Dr. Decrescenzo

Recent clinical trials with Dr. Decrescenzo

See all 10 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Andrew J. Decrescenzo received $12,601 in industry payments from 2017 to 2025

CMS Open Payments shows 384 general payments to Dr. Decrescenzo from 29 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 73% of the total. Arcutis Biotherapeutics, Inc. paid the most, $3,232.

General payments to Dr. Decrescenzo by program year, 2017 to 2025

General payments to Dr. Decrescenzo by kind, 2017 to 2025

$12.6Kin total
  • Food and beverage$9,25173%
  • Consulting fees$1,95015%
  • Education$7506%
  • Travel and lodging$6505%

Companies that paid Dr. Decrescenzo the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Decrescenzo

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Andrew J. Decrescenzo graduated from UTMB Health

Dr. Decrescenzo graduated from UTMB Health in 2017.

  1. Medical schoolUTMB Health
  2. Board certified in dermatologyAmerican Board of Dermatology
  3. Board certified in dermatopathologyAmerican Board of Dermatology

Source: Dmand AI Professional Profile Data

Dr. Andrew J. Decrescenzo accepts plans from 18 insurance carriers

Dr. Decrescenzo is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

  • Aetna
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • HCSC
  • Alliant Health Plans
  • Blue Cross Blue Shield of Massachusetts
  • Elevance
  • Humana
  • +10 more carriersWith a free account

Plan types Dr. Decrescenzo accepts, by number of carriers

  1. PPO12
  2. HMO9
  3. Medicare8
  4. POS4
  5. EPO2

Source: Dmand AI Insurance Network Data

Sources for Dr. Andrew J. Decrescenzo's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Andrew J. Decrescenzo

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Andrew J. Decrescenzo's NPI number?

Dr. Andrew J. Decrescenzo's NPI number is 1003342833. It was assigned on May 11, 2017, and it is active in the NPI Registry.

What kind of doctor is Dr. Andrew J. Decrescenzo?

Dr. Andrew J. Decrescenzo is a dermatologist in Spring, Texas. The primary specialty in the NPI Registry is Dermatology Physician (taxonomy code 207N00000X).

Where does Dr. Andrew J. Decrescenzo practice?

Dr. Decrescenzo practices at 9303 Pinecroft Dr, Spring, TX 77380. Dr. Decrescenzo's primary practice is The Woodlands Dermatology Associates PA in Spring, Texas. Dmand AI also links Dr. Decrescenzo to 2 medical groups and 1 group practice or clinic.

What is Dr. Andrew J. Decrescenzo's office phone number?

The practice phone on file for Dr. Decrescenzo is (281) 363-5050.

What is Dr. Andrew J. Decrescenzo's medical license number?

Dr. Decrescenzo holds Texas license S9489.

What medical group is Dr. Andrew J. Decrescenzo part of?

Dr. Decrescenzo is linked to UTMB Faculty Group Practice. Dmand AI links Dr. Decrescenzo to 2 more medical groups.

Does Dr. Andrew J. Decrescenzo accept Medicare?

Yes. CMS data shows Dr. Decrescenzo billed Medicare for 6,668 services in 2024, and Dr. Decrescenzo accepts Medicare assignment.

What is Dr. Andrew J. Decrescenzo's MIPS score?

Dr. Decrescenzo's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.

How many Medicare patients does Dr. Andrew J. Decrescenzo see?

CMS counts 2,469 Medicare patients who saw Dr. Decrescenzo in 2024, with an average age of 75.

Is Dr. Andrew J. Decrescenzo board certified?

Yes. Dr. Decrescenzo is board certified in dermatology by the American Board of Dermatology.

Show 8 more questionsShow fewer questions

What services does Dr. Andrew J. Decrescenzo bill to Medicare?

In 2024, Dr. Decrescenzo's most billed Medicare services were lab and pathology test (88305), surgery: skin and soft tissue (17003) and office visit, established patient (99213).

Where did Dr. Andrew J. Decrescenzo go to medical school?

Dr. Decrescenzo graduated from UTMB Health in 2017.

What drugs does Dr. Andrew J. Decrescenzo prescribe most?

In 2024 Medicare Part D data, Dr. Decrescenzo's most prescribed drugs by claims were Clobetasol Propionate, Fluconazole and Triamcinolone Acetonide.

Has Dr. Andrew J. Decrescenzo received payments from drug or device companies?

CMS Open Payments shows $12,601 in general payments to Dr. Decrescenzo from 29 companies from 2017 to 2025. The largest total came from Arcutis Biotherapeutics, Inc.

How long has Dr. Andrew J. Decrescenzo been practicing?

Dr. Decrescenzo graduated from medical school in 2017, 9 years ago.

Does Dr. Andrew J. Decrescenzo do research?

Dmand AI links 14 publications to Dr. Decrescenzo, published from 2013 to 2021. Dr. Decrescenzo has worked on 10 clinical trials.

Who does Dr. Andrew J. Decrescenzo publish with?

Dr. Decrescenzo's most frequent co-authors are Michael George Wilkerson, MD (4 shared papers), Rebecca Catherine Philips, MD (2 shared papers) and Marcus Zaayman (2 shared papers).

What insurance does Dr. Andrew J. Decrescenzo accept?

Dr. Decrescenzo is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

Selling to dermatology practices?

See dermatologists in Texas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)